200,000+ products from a single source!
sales@angenechem.com
Home > Recent Advances In The Synthesis Of C2-Spiropseudoindoxyls
Recent Advances In The Synthesis Of C2-Spiropseudoindoxyls
View angenechem, is a leading supplier of research chemistry to pharmaceutical companies like ark pharm
Yanling Ji,a Xianghong He,a Cheng Peng *a,b and Wei Huang
Metal-catalyzed synthesis
Due to their high efficiency, metal-catalytic reactions have become a research hotspot in chemical synthesis.6 Metal catalysis can synthesize many C2-spiropseudoindoxyl structures from simple substrates.
In 2011, Ramana and co-workers described a palladiumcatalyzed intramolecular addition reaction of nitro- and alcohol units across alkyne 1, resulting in C2-spiropseudoindoxyl derivatives 2. Optimal reaction conditions were 5 mol% Pd(CH3CN)2Cl2 as the catalyst in CH3CN at room temperature(Scheme 1a).7 With all the hexynols 1b and propargyl glycol derivatives 1c, C2-spiropseudoindoxyl derivatives were synthesized in good yields (78–84%). However, the cycloisomerization of 1a resulted in mixtures with a lower yield (32–38%).
The proposed reaction mechanism explains the synthesis of C2-spiropseudoindoxyl derivatives from 5-exo-dig nitroalkyne via cycloisomerization, nucleophilic addition and reduction. As shown in Scheme 1b, a Pd-mediated cycle of 5-exo-dig nitroalkyne cyclization produces int. 1, which undergoes an internal N–O bond redox reaction to generate the intermediate metal carbene int. 2. Nitrogen addition to the metal carbene affords isatogen int. 3 and one molecule of PdCl2. Subsequent intramolecular addition of an OH group leads to int. 4, and subsequent reduction of the N–O bond produces the C spiropseudoindoxyl derivatives 2. The same research group subsequently subjected similar substrates 3 to the cycloisomerization–cycloaddition cascade, generating the tricyclic core of C2 spiropseudoindoxyl derivatives 4. 8 As shown in Scheme 2, the optimal reaction conditions proved to be 10 mol% AuCl(PPh3) as the catalyst, 20 mol% AgSbF6 as the additive, and reaction temperature of
0 °C for 4 h. The reaction was tolerant of substituents on the alkene and aromatic rings and of protecting groups on the nitrogen. The presence of substituents such as MeO– and Me–on the aryl ring produced the best results. However, the presence of N–Ms, N–Ts, or –Cl groups on the aromatic ring reduced the yield of the desired product (13–26%) because these groups rendered the reaction less selective, and compounds 4′ or 4″ were also generated as by-products. The researchers proposed the intermediate int. 5 as shown in Scheme 2.
Subsequently, Wang and coworkers used the o-alkynylnitrobenzenes 5 as substrates to directly synthesize N,N′-ketal spiropseudoindoxyls 6 for the first time (Scheme 3).9 Optimal reaction conditions were tmphen (3,4,7,8-tetramethyl-1,10-phenanthroline) (40 mol%) as the ligand, Pd(OAc)2 (20 mol%) as the catalyst, Mo(CO)6 (1 equiv.) as the reductant, and CF3CH2OH as the solvent at 70 °C for 8 h. The reaction was tolerant of a wide range of o-alkynylnitrobenzenes (X = Ts) and functional groups. Notably, substituents at C-1 or C-4 on the benzene ring reduced the yield (27–45%), probably because of steric hindrance. The reaction worked well when the methylphenylsulfonyl group (X = Ts) was changed to a substituted benzenesulfonyl group or to a thiophen-2-ylsulfonyl, cyclopropyl or methyl sulfonyl group. This is a simple and efficient method to synthesize a wide range of C2-spiropseudoindoxyls, several of which show bactericidal activity.
In 2015, Verniest’s group reported a similar reaction in which Au(III) catalyzed the cycloisomerization of o-nitrophenylpropiolamides 7, affording novel C2-spiropseudoindoxyls 8 in high yields (Scheme 4).10 The optimal reaction conditions were toluene as the solvent, 5 mol% Au(III) as the catalyst, and room temperature for 0.5 h. The resulting polycyclic spiropseudoindoxyl int. 9 was converted to single-diastereomer spiropyrryloxys 8 in 91–99% yields under hydrogen at atmospheric pressure in the presence of 10% Pd/C. This reaction tolerated various substituents that exerted different electronic effects on the substrates. To elucidate the mechanism of this reaction, the group performed preliminary density functional theory (DFT) calculations. The amide oxygen facilitates ring opening in int. 6 via formation of the remarkable oxirane structure int. 7, which is easily converted to isatogen int. 8. DFT calculations suggest that, contrary to the conventional assumptions, the transformation does not involve gold carbene (int. 7′). Instead, isatogen int. 8 undergoes [3 + 2] intramolecular cycloaddition, and hydrogen reduction affords spiropseudoindoxyls 8. This process can allow reduction of benzylic ketones under
certain conditions.
Tu’s team described a C2-selective cyclization of gold-catalyzed alkynyl oxime 9 with an electron-withdrawing protecting group to synthesize a useful C2-spiropseudoindoxyl structure(Scheme 5).11 The optimal reaction conditions were Au(PPh3) Cl/AgOTf (5 mol%) as the catalyst and CH2Cl2 as the solution at room temperature in 0.5 h, giving a useful spiro-indolenine derivative 10. The reaction tolerated indole substrates with propyl (Pr), isopropyl (i-Pr), or Cy (cyclohexyl) on the alkyne chain and with N-protecting groups, giving the desired products in good to excellent yields (51–98%). The researchers proposed a mechanism in Scheme 5b. Isotopic labeling experiments confirmed that H2O participates in this 5-exo-dig cyclization.
Treating compound 9 with Au(PPh3)Cl/AgOTf (5 mol%) in ultradry CH2Cl2 saturated with H2 18O afforded product 18O-labeled 10, which was confirmed by electrospray ionization-based mass spectrometry and by high-resolution mass spectrometry.
In 2015, Pal’s group proposed an unprecedented Cu-catalyzed cascade reaction of cyclopenta[b]indoles 11 to construct C2-spiropseudoindoxyls 12 (Scheme 6).12 By screening the experimental conditions, the optimal reaction conditions were found to be 10 mol% of CuI as the catalyst in a solution mixture of DMF and H2O (7 : 3) at 120 °C for 1.5–4 h with the assistance of air. This reaction tolerates cyclopentanediol 11 containing alkyl, aryl and heteroaryl sulfonamide groups and offers the desired product in good to acceptable yields (35–72%). It is worth noting that when the reaction was performed under nitrogen protection, the reaction time was increased to 8 hours, which indicated the air played an important role in the reaction. The reaction rate is higher in the aqueous DMF solution than in pure DMF solution potentially because the presence of water greatly enhances the ability to absorb and retain higher volumes of oxygen through the DMF aqueous solution. However, due to the low solubility of the aqueous solution, the presence of a larger amount of water does not further improve the reaction time or yield. The proposed reaction mechanism according to the reaction phenomenon in the experimental screening process is shown in Scheme 6b.
In 2016, Li’s group synthesized spiropseudoindoxyl 14 via copper-catalyzed spirocyclization of 1-H-indole-2-carboxamide 13 bearing an N-phenyl ring (Scheme 7).13 The optimal reaction conditions were 5 mol% Cu(OTf )2 and 3.0 equivalents of tert-butylhydroperoxide (TBHP) in dichloroethane (DCE) at 60 °C for 4 h. The reaction tolerated diverse substituents on the substrates, including different N-alkyl substituents (R1) on the amide group, different N-aryl substituents (R2), and chlorine or fluorine substituents on the indole moiety (R3).
Products were obtained in good yields (63–71%) in the presence of various electron-donating groups (R2) at the para-position of the N-phenyl ring. However, product yields were lower when electron-withdrawing groups weakened the nucleophilicity of the N-phenyl ring. Indole-2-carboxamide with tetrahydroquinoline on the amide was easily cyclized under standard reaction conditions to afford the highly strained polycyclic spiroindole in 45% yield. These results led to two possible mechanistic pathways (Scheme 7b). Regardless of the mechanism, the process transforms the readily available starting
materials rapidly and efficiently into C2-spiro-indolyl groups under mild conditions. These C2-spiro-indolyl groups are ubiquitous structural units in indole alkaloids yet are generally
difficult to prepare.
In 2014, Li’s group demonstrated Rh(III)-catalyzed hydrogenation coupling of N-sulfonyl 2-aminobenzaldehyde 15 with olefins 16 (Scheme 8).14 The optimal reaction conditions were [Cp*RhCl2]2 (2.5 mol%) as the catalyst, Ag2CO3 (1 equiv.) as the base, and DCE as the solvent at 120 °C under argon for 18 h. This reaction tolerated various electron-donating or electronwithdrawing substitutions on the phenyl group, providing the expected product in 47–86% yield. The researchers proposed two possible intermediates (Scheme 8).
Hypervalent Iodine-Mediated Annulation Reaction
Hypervalent iodine reagents are easy to handle, environmentally friendly, “green” nonmetallic oxidants that have undergone explosive development in oxidative annulation reactions.Iodine reagent-mediated oxidative cyclization is widely used to synthesize various heterocyclic compounds, such as aziridine, cyclopropane, oxetane, azetidine, and dihydrofuran.15 Recent studies have shown that iodine reagents can also be used to mediate the synthesis of C2-spiropseudoindoxyl.
Fan and coworkers investigated the synthesis of a C2-spiropseudoindoxyl compound 19 from an acyclic precursor 18, iodobenzene diacetate, and tetrabutylammonium iodide via iodophenyltriene(III)-mediated tandem carbon–hydrogen bond oxidation (Scheme 9).16 The reaction proceeded smoothly at room temperature in DMF as the solvent and the combination of PhI(OAc)2 (2.0 equiv.) and Bu4NI (2.0 equiv.) as the oxidant. The desired products were obtained in high yields (72–90%). This reaction tolerated electron-donating and electron-withdrawing substituents at the para-positions of the benzene ring in R1. When the cyclohexane-1,3-dione group was replaced by the 5,5-dimethylcyclohexane-1,3-dione group, the corresponding products also formed in good yields (79–81%).
Remarkably, no desired product formed when an Ms, benzoyl, or acetyl protecting group was used, indicating that the Ts protecting group in substrate 18 is essential for formation of the oxa-aza spirobicyclic product. The researchers proposed a mechanism (Scheme 9b). This reaction was the first to use a hypervalent iodine reagent to synthesize C2-spiropseudoindoxyl. In 2015, Du’s team used the same hypervalent iodine reagent (PIDA)-mediated cascade cyclization to achieve the unique trans-aminocarboxylation of diarylalkyl and oxoaminocarboxylates 20, resulting in C2-spiropseudoindoxyl 22
(Scheme 10).17 First, the Lewis acid BF3·Et2O was added to a solution of the substrate 20 in DCE at room temperature. The mixture was stirred at 80 °C overnight to synthesize 6-endo intermediate 21.
Subsequently, 2.1 equivalents of PIDA were gradually added to generate the final product 22. The reaction tolerated a variety of substrates with electron-donating or electron-withdrawing groups at the 4-position of the phenyl ring (R1, R2). The researchers proposed a plausible mechanism (Scheme 10b) in which the acid moiety in 20 is activated by BF3·Et2O and converted to the ylide intermediate int. 11,
which undergoes tautomerization/aromatization to obtain intermediate int. 12. This compound undergoes intramolecular 1,4-addition to afford 6-endo-dig intermediate 21.
Oxidation of 21 by PIDA, accompanied by the loss of one acetic acid, produces intermediate int. 13, which undergoes intramolecular cyclization to yield intermediate int. 14, and one molecule of iodobenzene and acetate anions. The acetate anion promotes protonation of the intermediate int. 14 to produce intermediate int. 15 with two additional rings. Following activation by BF3·Et2O, PIDA oxidizes int. 15 while losing an acetate anion, producing intermediate int. 16.
Nucleophilic attack by the acetate anion at the most electrophilic carbon in intermediate int. 16 generates intermediate int.17 and liberates one iodobenzene and one acetate anion. The released acetate anion promotes the ring opening of the lactone moiety in int. 17. Subsequent 1,2-addition of the nucleophilic benzoate to the imine moiety affords the final C2-spiropseudoindoxyl product 22. The same research group later used hypervalent iodine reagents in single-oxidant cascade cyclization to oxidize the diarylacetylene compounds 23a and form a series of novel C2-spiropseudoindoxyl compounds 24a (Scheme 11).18 Optimal reaction conditions were PhI(OCOCF3)2 as the oxidizing agent, DCM as the solvent, and temperature between −20 and 0 °C.
The reaction was unaffected by various electron-deficient and electron-rich substituents on the phenyl ring of the aniline or benzamide moiety, with the desired spiro-compounds generated in good yields (51–88%). Product yield was, however, substantially reduced when the substrate exerted a spatial effect. Replacing the OMe group with an aryl or alkyl group led to the desired products in moderate yields (49–69%). In fact, replacing NH–OMe in the substrate by OH gave a satisfactory yield(57–92%). Under similar conditions, substrates 23b could be transformed to obtain the desired products 24b in good yields.
The research group proposed two reaction mechanisms(Scheme 11b). In path a, the intermediate int. 18 is obtained by reacting substrate 23 with 2.0 equivalents of the oxidant PhI(OCOCF3)2, which also releases one molecule of trifluoroacetic acid. Subsequent intramolecular C–O bond formation and release of one molecule of iodobenzene and a trifluoroacetate anion generate the cationic intermediate int. 19. The energetically favorable combination of the negatively charged trifluoroacetate and the positively charged carbon center in int. 19 provide intermediate int. 20. Oxidation of the tosylamide moiety provides intermediate int. 21 and another molecule of trifluoroacetic acid. Subsequent intramolecular indolization generates intermediate int. 22, whose most electrophilic carbon is again attacked by the nucleophilic trifluoroacetate anion, affording the intermediate int. 23, which is converted to the iminium int. 24. Release of the trifluoroacetate anion forms intermediate int. 24, which undergoes ring opening to form iminium int. 25, which in turn rapidly cyclizes to provide the desired spirocyclic compound 24.
In the alternative mechanistic path b, activation of the triple bond by PhI(OCOCF3)2 produces electrophilic intermediate int. 26, which reacts with nucleophilic benzamide to generate intermediate int. 27. Release of one molecule of iodobenzene from int. 27 produces the same intermediate int. 20. PhI(OCOCF3)2 again activates the intramolecular double bond to form the intermediate int. 28, which generates intermediate int. 29 via an electrophilic reaction. Intermediate int. 29 is converted into oxonium int. 22, accompanied by the loss of one molecule of iodobenzene. The intermediate int. 22 is converted into the final product 24 via a process similar to that in path a. This work was the first report of the complex spirocyclization of alkyne substrates under metal-free conditions. This
unprecedented cascade reaction includes not only two sequential C–N/C–O bond formations, but also the insertion of carbonyl oxygen.
The same research group later synthesized a novel class of C2-spiropseudoindoxyls 26 using the same hypervalent iodine reagent oxidative-cascade annulation reaction of 2-sulfonamido-N-phenylpropiolamide derivatives 25 (Scheme 12).19 The optimal reaction conditions were 2.2 equivalents of PhI(OCOCF3)2 as the sole oxidant at 0 °C in DCE. These optimized conditions were used to generate a series of C2-spiropseudoindoxyl compounds in moderate to good yields (43–90%).
This cascade oxidation with hypervalent iodine reagents broadly tolerated electrons on the benzene ring of 2-aminobenzyl 26 (R1 and R2). The substituent on the nitrogen atom (R3) was tosyl, methanesulfonyl, phenylsulfonyl, or p-chlorobenzenesulfonyl, and the substituent at R4 was ethyl or n-butyl. Based on control experiments, the researchers proposed two rational mechanisms for PIFA-mediated tandem oxidation(Scheme 12b). In both cases, spirocyclization involves iodine(III)-mediated cascade formation of C(sp2)–C(sp) and C(sp2)–N bonds, with the transfer of a carbonyl group from the hypervalent iodine reagent.
View angenechem, is a leading supplier of research chemistry to pharmaceutical companies like ark pharm:
CAS No. 10024-78-9Catalog No.:AG0001D8 MDL No.: MF:C11H25N MW:171.3229 |
CAS No. 10024-89-2Morpholine, hydrochloride (1:1) Catalog No.:AG0001D7 MDL No.:MFCD00035287 MF:C4H10ClNO MW:123.5813 |
CAS No. 10024-90-5Ethanone, 1-(4-methoxy-3-methylphenyl)- Catalog No.:AG0001D6 MDL No.:MFCD01673307 MF:C10H12O2 MW:164.2011 |
CAS No. 100240-05-9Catalog No.:AG0001D3 MDL No.:MFCD03426313 MF:C11H16N2 MW:176.2581 |
CAS No. 100240-20-8Piperidine, 3-(3-fluorophenyl)-, hydrochloride (1:1) Catalog No.:AG0001D2 MDL No.:MFCD02178932 MF:C11H15ClFN MW:215.6949 |
CAS No. 100240-32-2Pyridazine, 3-chloro-6-[4-(2-fluorophenyl)-1-piperazinyl]- Catalog No.:AG0001D1 MDL No.: MF:C14H14ClFN4 MW:292.7392 |
CAS No. 100245-65-62,4-Imidazolidinedione, 3-bromo-1-chloro-5-ethyl-5-methyl- Catalog No.:AG0001DI MDL No.: MF:C6H8BrClN2O2 MW:255.4969 |
CAS No. 100246-04-64-Benzoxazolecarboxylic acid, 2,3-dihydro-2-oxo-, methyl ester Catalog No.:AG0001DH MDL No.:MFCD11111730 MF:C9H7NO4 MW:193.1562 |
CAS No. 100246-10-44-Quinazolinecarboxylic acid, 2-amino- Catalog No.:AG0001DG MDL No.:MFCD18377829 MF:C9H7N3O2 MW:189.1708 |
CAS No. 100246-69-3Catalog No.:AG0001DF MDL No.: MF:C12H23ClO MW:218.7634 |
CAS No. 100247-06-1Pyrrolidine, 1-cyclohexyl-2,5-dimethyl- Catalog No.:AG0001DE MDL No.: MF:C12H23N MW:181.3177 |
CAS No. 100247-13-0Cyclohexaneacetamide, 4-(1,1-dimethylethyl)- Catalog No.:AG0001DD MDL No.: MF:C12H23NO MW:197.3171 |
CAS No. 100247-99-2Catalog No.:AG0001DC MDL No.: MF:C12H23NO4 MW:245.3153 |
CAS No. 100248-74-6Urea, N-(2-chloroethyl)-N'-[(2,6-dimethylphenyl)methyl]- Catalog No.:AG0001DB MDL No.: MF:C12H17ClN2O MW:240.7292 |
CAS No. 100248-86-0Urea, N-(2-chloroethyl)-N'-[(3,4-dimethoxyphenyl)methyl]- Catalog No.:AG0001DA MDL No.: MF:C12H17ClN2O3 MW:272.7280 |
CAS No. 100249-12-5Benzeneethanamine, N,N-bis(2-chloroethyl)-, hydrochloride (1:1) Catalog No.:AG0001D9 MDL No.: MF:C12H18Cl3N MW:282.6370 |
CAS No. 10025-64-6Perchloric acid, zinc salt, hydrate (2:1:6) Catalog No.:AG0001DW MDL No.:MFCD00150370 MF:Cl2H12O14Zn MW:372.3729 |
CAS No. 10025-65-7Catalog No.:AG0001DV MDL No.:MFCD00011181 MF:Cl2Pt MW:265.9840 |
CAS No. 10025-66-8Catalog No.:AG0001DU MDL No.: MF:Cl2Ra MW:296.9060 |
CAS No. 10025-69-1Tin chloride (SnCl2), dihydrate (8CI,9CI) Catalog No.:AG0001DR MDL No.:MFCD00149863 MF:Cl2O2Sn MW:221.6058 |
CAS No. 10025-70-4Strontium chloride (SrCl2), hydrate (1:6) Catalog No.:AG0001DQ MDL No.:MFCD00149865 MF:Cl2O6Sr MW:254.5224 |
CAS No. 10025-73-7Catalog No.:AG0001DP MDL No.:MFCD00010948 MF:Cl3Cr MW:158.3551 |
CAS No. 10025-77-1Iron chloride (FeCl3), hexahydrate (8CI,9CI) Catalog No.:AG0001DL MDL No.:MFCD00149712 MF:Cl2FeO6 MW:222.7474 |
CAS No. 10025-82-8Catalog No.:AG0001DJ MDL No.:MFCD00011058 MF:Cl8In4++++ MW:742.8960 |
CAS No. 10025-83-9Catalog No.:AG0001EJ MDL No.:MFCD00011063 MF:Cl15Ir5 MW:1492.8800 |
CAS No. 10025-97-5Catalog No.:AG0001ED MDL No.:MFCD00016155 MF:Cl8Ir2 MW:668.0580 |
CAS No. 100251-95-4Phenol, 2-[(dimethylamino)methyl]-3,5,6-trimethyl- Catalog No.:AG0001EC MDL No.: MF:C12H19NO MW:193.2854 |
CAS No. 100252-25-3Ethanamine, N,N-dimethyl-2-(2-phenoxyethoxy)- Catalog No.:AG0001EB MDL No.: MF:C12H19NO2 MW:209.2848 |
CAS No. 100252-26-4Catalog No.:AG0001EA MDL No.: MF:C12H19NO2 MW:209.2848 |
CAS No. 100253-53-04H-1,3-Thiazin-2-amine, N-(4-ethoxyphenyl)-5,6-dihydro- Catalog No.:AG0001E9 MDL No.:MFCD03152758 MF:C12H16N2OS MW:236.3332 |
CAS No. 100253-83-6Propanamide, 2,2-dimethyl-N-nitroso-N-(phenylmethyl)- Catalog No.:AG0001E8 MDL No.: MF:C12H16N2O2 MW:220.2676 |
CAS No. 1002535-21-8Benzoic acid, 3-(1H-pyrazol-4-yl)- Catalog No.:AG0001DY MDL No.:MFCD06739075 MF:C10H8N2O2 MW:188.1827 |
CAS No. 100254-21-5Acetamide, N-(2,3-dihydro-1,4-benzodioxin-6-yl)-2-(ethylamino)- Catalog No.:AG0001E7 MDL No.:MFCD04628440 MF:C12H16N2O3 MW:236.2670 |
CAS No. 100255-05-8Benzene, 1,5-bis(1-methylethoxy)-2,4-dinitro- Catalog No.:AG0001E6 MDL No.: MF:C12H16N2O6 MW:284.2652 |
CAS No. 1002556-37-71H-Naphtho[2,3-c]pyran-5,10-dione, 3,4-dihydro-1-methoxy- Catalog No.:AG0001DX MDL No.: MF:C14H12O4 MW:244.2427 |
CAS No. 100256-20-0Benzene, 1-(2-propen-1-yl)-2-propoxy- Catalog No.:AG0001E5 MDL No.: MF:C12H16O MW:176.2548 |
CAS No. 100256-29-9Ethanone, 1-[4-(butylthio)phenyl]- Catalog No.:AG0001E4 MDL No.: MF:C12H16OS MW:208.3198 |
CAS No. 100256-35-7Ethanone, 1-(4-methoxy-3-propylphenyl)- Catalog No.:AG0001E3 MDL No.: MF:C12H16O2 MW:192.2542 |
CAS No. 100256-51-7Catalog No.:AG0001E2 MDL No.: MF:C12H16O2 MW:192.2542 |
CAS No. 100256-61-9Catalog No.:AG0001E1 MDL No.: MF:C12H16O2 MW:192.2542 |
CAS No. 100256-84-6Acetic acid, 2-(2-ethylphenoxy)-, ethyl ester Catalog No.:AG0001E0 MDL No.: MF:C12H16O3 MW:208.2536 |
CAS No. 100256-89-1Benzaldehyde, 3-ethoxy-2-propoxy- Catalog No.:AG0001DZ MDL No.:MFCD05263779 MF:C12H16O3 MW:208.2536 |
CAS No. 100256-94-8Benzoic acid, 4-propoxy-, ethyl ester Catalog No.:AG0001EU MDL No.: MF:C12H16O3 MW:208.2536 |
CAS No. 1002566-99-52-Piperidinone, 5-amino-, (5R)- Catalog No.:AG0001EK MDL No.: MF:C5H10N2O MW:114.1457 |
CAS No. 100257-07-6Cyclonona[b]pyran-2(5H)-one, 6,7,8,9,10,11-hexahydro-4-hydroxy- Catalog No.:AG0001ET MDL No.: MF:C12H16O3 MW:208.2536 |
CAS No. 100257-46-3Ethanone, 1-[4-(butylsulfonyl)phenyl]- Catalog No.:AG0001ES MDL No.: MF:C12H16O3S MW:240.3186 |
CAS No. 100258-36-4Benzene, [(cyclopentylmethyl)thio]- Catalog No.:AG0001ER MDL No.: MF:C12H16S MW:192.3204 |
CAS No. 100258-40-02,5,8,11,14,17,20,23,26-Nonaoxaoctacosane, 27-methyl- Catalog No.:AG0001EQ MDL No.: MF:C20H42O9 MW:426.5421 |
CAS No. 100258-41-12,5,8,11,14,17,20,23,26,29-Decaoxahentriacontane, 30-methyl- Catalog No.:AG0001EP MDL No.: MF:C22H46O10 MW:470.5946 |
CAS No. 100258-42-22,5,8,11,14,17,20,23-Octaoxapentacosane, 24-methyl- Catalog No.:AG0001EO MDL No.: MF:C18H38O8 MW:382.4895 |
CAS No. 100258-43-32,5,8,11,14,17,20-Heptaoxadocosane, 21-methyl- Catalog No.:AG0001EN MDL No.: MF:C16H34O7 MW:338.4370 |
CAS No. 100258-45-5Octadecanoic acid, 12-[(1-oxooctadecyl)oxy]-, 2-hexyldecyl ester Catalog No.:AG0001EM MDL No.: MF:C52H102O4 MW:791.3639 |
CAS No. 100258-46-6Octadecanoic acid, 12-[(1-oxooctadecyl)oxy]-, 2-octyldecyl ester Catalog No.:AG0001EL MDL No.: MF:C54H106O4 MW:819.4170 |
CAS No. 10026-22-9Nitric acid, cobalt(2+) salt, hydrate (2:1:6) Catalog No.:AG0001EZ MDL No.:MFCD00149647 MF:CoH12N2O12 MW:291.0347 |
CAS No. 10026-23-0Selenious acid, cobalt(2+) salt (1:1) (9CI) Catalog No.:AG0001EY MDL No.: MF:CoO3Se MW:185.8914 |
CAS No. 10026-24-1Sulfuric acid, cobalt(2+) salt, hydrate (1:1:7) Catalog No.:AG0001EX MDL No.:MFCD00149658 MF:CoH14O11S MW:281.1028 |
CAS No. 10026-54-7α-D-Glucopyranose, 2-(acetylamino)-2-deoxy-6-O-(triphenylmethyl)-, 1,3,4-triacetate Catalog No.:AG0001EW MDL No.:MFCD00275344 MF:C33H35NO9 MW:589.6323 |
CAS No. 10026-76-3Ethanol, 2,2'-[(1-methylheptyl)imino]di- (8CI) Catalog No.:AG0001EV MDL No.: MF:C12H27NO2 MW:217.3483 |
CAS No. 100260-12-6Arsonium, (2-methoxy-2-oxoethyl)triphenyl-, iodide (1:1) Catalog No.:AG0001FO MDL No.: MF:C21H20AsIO2 MW:506.2084 |
CAS No. 100264-58-21-Benzothiopyrylium, 2-(4H-1-benzothiopyran-3-yl)-, perchlorate (9CI) Catalog No.:AG0001FN MDL No.: MF:C18H15ClO4S2 MW:394.8923 |
CAS No. 1002651-00-42-Propanone, 1-(3,5-dimethyl-4-nitro-1H-pyrazol-1-yl)- Catalog No.:AG0001FJ MDL No.:MFCD03885073 MF:C8H11N3O3 MW:197.1912 |
CAS No. 1002651-65-11H-Pyrazole-3-methanamine, 1-ethyl-N-methyl- Catalog No.:AG0001FI MDL No.:MFCD03419813 MF:C7H13N3 MW:139.1982 |
CAS No. 100267-42-3Phenol, 2,6-bis[(5-chloro-2-hydroxyphenyl)methyl]-4-methyl- Catalog No.:AG0001FM MDL No.: MF:C21H18Cl2O3 MW:389.2718 |
CAS No. 10027-06-22-Propenoic acid, bicyclo[2.2.1]hept-2-yl ester Catalog No.:AG0001FX MDL No.: MF:C10H14O2 MW:166.2170 |
CAS No. 10027-07-3Catalog No.:AG0001FW MDL No.:MFCD00000764 MF:C8H12Cl2O2 MW:211.0857 |
CAS No. 10027-28-8Butanedioic acid, 2-sulfo-, 1,4-dioctadecyl ester, sodium salt (1:1) Catalog No.:AG0001FV MDL No.: MF:C40H78NaO7S MW:726.0979 |
CAS No. 10027-30-21,2-Benzenedicarboxylic acid, copper(2+) salt (1:1) Catalog No.:AG0001FU MDL No.: MF:C8H4CuO4 MW:227.6610 |
CAS No. 10027-69-72-Propanesulfonothioic acid, S-(1-methylethyl) ester Catalog No.:AG0001FT MDL No.: MF:C6H14O2S2 MW:182.3042 |
CAS No. 10027-71-1Hydroperoxide, methoxyphenylmethyl Catalog No.:AG0001FS MDL No.: MF:C8H10O3 MW:154.1632 |
CAS No. 10027-72-2Hydroperoxide, methoxymethyl (8CI,9CI) Catalog No.:AG0001FR MDL No.: MF:C2H6O3 MW:78.0672 |
CAS No. 10027-74-4Hydroperoxide, 1-methoxy-1-methylethyl Catalog No.:AG0001FQ MDL No.: MF:C4H10O3 MW:106.1204 |
CAS No. 10027-80-21,2-Cyclohexanediamine, hydrochloride (1:2), (1R,2S)-rel- Catalog No.:AG0001FP MDL No.:MFCD19440709 MF:C6H16Cl2N2 MW:187.1106 |
CAS No. 1002726-59-12H-Pyrido[3,2-b]-1,4-oxazin-3(4H)-one, 2,2-dimethyl-6-nitro- Catalog No.:AG0001FH MDL No.:MFCD10000811 MF:C9H9N3O4 MW:223.1855 |
CAS No. 1002726-62-62H-Pyrido[3,2-b]-1,4-oxazin-3(4H)-one, 6-amino-2,2-dimethyl- Catalog No.:AG0001FG MDL No.:MFCD10000812 MF:C9H11N3O2 MW:193.2025 |
CAS No. 1002726-80-83-Piperidinol, 1-(4-amino-2-fluorophenyl)- Catalog No.:AG0001FF MDL No.: MF:C11H15FN2O MW:210.2480 |
CAS No. 1002727-87-82H-1-Benzopyran, 3,4-dihydro-6-isocyanato- Catalog No.:AG0001FE MDL No.:MFCD12198109 MF:C10H9NO2 MW:175.1840 |
CAS No. 1002727-88-92H-1-Benzopyran, 3,4-dihydro-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)- Catalog No.:AG0001FD MDL No.:MFCD12028565 MF:C15H21BO3 MW:260.1364 |
CAS No. 1002727-89-0Benzenesulfonyl chloride, 4-(phenoxymethyl)- Catalog No.:AG0001FC MDL No.:MFCD09966154 MF:C13H11ClO3S MW:282.7426 |
CAS No. 1002727-90-3Benzoic acid, 4-(2-thienylmethyl)- Catalog No.:AG0001FB MDL No.:MFCD12198116 MF:C12H10O2S MW:218.2716 |
CAS No. 100273-54-91,3,5-Triazine, hexahydro-1,3,5-tris(2-methylene-1-oxopentyl)- (9CI) Catalog No.:AG0001FL MDL No.: MF:C21H33N3O3 MW:375.5050 |
CAS No. 1002732-10-61,3-Pyrrolidinedicarboxylic acid, 4-(4-fluorophenyl)-, 1-(1,1-dimethylethyl) ester, (3S,4R)- Catalog No.:AG0001FA MDL No.:MFCD16879059 MF:C16H19FNO4- MW:308.3248 |
CAS No. 100275-94-31,4-Benzodioxin, 2,3-dihydro-6-isocyanato- Catalog No.:AG0001FK MDL No.:MFCD02677705 MF:C9H7NO3 MW:177.1568 |
CAS No. 1002750-44-81H-Benzimidazole-1-carboxylic acid, 2-(chloromethyl)-5-fluoro-, 1,1-dimethylethyl ester Catalog No.:AG0001F9 MDL No.: MF:C13H14ClFN2O2 MW:284.7139 |
CAS No. 1002752-55-7Benzenepropanoic acid, α-(3-bromophenyl)-4-chloro-, (αS)- Catalog No.:AG0001G0 MDL No.:MFCD13152338 MF:C15H12BrClO2 MW:339.6116 |
CAS No. 1002754-88-2Boronic acid, B-[4-(3-buten-1-ylsulfonyl)phenyl]- Catalog No.:AG0001FZ MDL No.: MF:C10H13BO4S MW:240.0838 |
CAS No. 100276-81-1Pyrimidine, 2,4-diiodo-5-(methylthio)- Catalog No.:AG0001GE MDL No.: MF:C5H4I2N2S MW:377.9726 |
CAS No. 1002761-99-0Benzonitrile, 3-amino-4-bromo-5-methyl- Catalog No.:AG0001FY MDL No.: MF:C8H7BrN2 MW:211.0586 |
CAS No. 100277-27-8(Tetrahydro-2H-thiopyran-4-yl);methanol Catalog No.:AG0001GD MDL No.:MFCD09966150 MF:C6H12OS MW:132.2239 |
CAS No. 100277-62-1Catalog No.:AG0001GC MDL No.: MF:C22H31N3O5S MW:449.5636 |
CAS No. 100277-95-0Phosphonothioic acid, phenyl-, O-phenyl ester (6CI,9CI) Catalog No.:AG0001GB MDL No.: MF:C12H10O2PS- MW:249.2454 |
CAS No. 100278-53-3Benzoic acid, 4-[(4-methoxybenzoyl)amino]-, hydrazide Catalog No.:AG0001GA MDL No.: MF:C15H15N3O3 MW:285.2979 |
CAS No. 100278-67-9Phenol, 3-methyl-6-nitro-2-(2-propen-1-yl)- Catalog No.:AG0001G9 MDL No.: MF:C10H11NO3 MW:193.1992 |
CAS No. 100278-74-8Phenol, 5-chloro-4-methyl-2-nitro- Catalog No.:AG0001G8 MDL No.:MFCD19374209 MF:C7H6ClNO3 MW:187.5804 |
CAS No. 100278-86-211-Hexadecenoyl fluoride, (Z)- (9CI) Catalog No.:AG0001G7 MDL No.: MF:C16H29FO MW:256.3993 |
CAS No. 100278-98-6Benzamide, N-[[[2-chloro-4-[(1,1,2,2-tetrafluoroethyl)thio]phenyl]amino]carbonyl]-2,6-difluoro- Catalog No.:AG0001G6 MDL No.: MF:C16H9ClF6N2O2S MW:442.7633 |
CAS No. 100279-18-3Benzamide, N-[[[2,5-dichloro-4-[(1,1,2,2-tetrafluoroethyl)thio]phenyl]amino]carbonyl]-2,6-difluoro- Catalog No.:AG0001G5 MDL No.: MF:C16H8Cl2F6N2O2S MW:477.2083 |
CAS No. 100279-32-1Benzamide, N-[[[4-[(2-chloro-1,1,2-trifluoroethyl)thio]-2-fluorophenyl]amino]carbonyl]-2,6-difluoro- Catalog No.:AG0001G4 MDL No.: MF:C16H9ClF6N2O2S MW:442.7633 |
CAS No. 100279-41-2Catalog No.:AG0001G3 MDL No.: MF:C16H8Cl3F5N2O2S MW:493.6629 |
CAS No. 100279-97-8Benzamide, N-[[[2-bromo-4-[(2-chloro-1,1,2-trifluoroethyl)thio]phenyl]amino]carbonyl]-2,6-difluoro- Catalog No.:AG0001G2 MDL No.: MF:C16H9BrClF5N2O2S MW:503.6689 |
CAS No. 100279-99-0Catalog No.:AG0001G1 MDL No.: MF:C18H14ClF5N2O2S MW:452.8260 |
CAS No. 10028-14-5Catalog No.:AG0001GM MDL No.: MF:No MW:259.1000 |
CAS No. 10028-15-6Catalog No.:AG0001GL MDL No.: MF:O3 MW:47.9982 |
CAS No. 10028-18-9Catalog No.:AG0001GK MDL No.:MFCD00016263 MF:F2Ni MW:96.6902 |
CAS No. 10028-22-5Sulfuric acid, iron(3+) salt (3:2) Catalog No.:AG0001GJ MDL No.:MFCD00011007 MF:Fe2O12S3 MW:399.8778 |
CAS No. 10028-24-7Phosphoric acid, disodium salt, dihydrate (8CI,9CI) Catalog No.:AG0001GI MDL No.:MFCD00149182 MF:H5Na2O6P MW:177.9894 |
CAS No. 10028-26-9Sulfuric acid, magnesium salt (2:1) (9CI) Catalog No.:AG0001GH MDL No.: MF:H2MgO8S2 MW:218.4461 |
CAS No. 10028-34-92-Azabicyclo[2.2.2]octane-3,6-dione, 2-(phenylmethyl)- Catalog No.:AG0001GG MDL No.: MF:C14H15NO2 MW:229.2744 |
CAS No. 10028-70-31,4-Benzenedicarboxylic acid, sodium salt (1:2) Catalog No.:AG0001GF MDL No.:MFCD00013137 MF:C8H4Na2O4 MW:210.0945 |
CAS No. 100280-01-1Catalog No.:AG0001H4 MDL No.: MF:C18H14ClF5N2O2S MW:452.8260 |
CAS No. 100280-10-2Benzenamine, 2-fluoro-4-[(1,1,2,2-tetrafluoroethyl)thio]- Catalog No.:AG0001H3 MDL No.: MF:C8H6F5NS MW:243.1970 |
CAS No. 100281-05-8Silacyclohexan-2-one, 1,1,3-trimethyl- Catalog No.:AG0001H2 MDL No.: MF:C8H16OSi MW:156.2975 |
CAS No. 100281-12-71,5-Hexadien-3-ol, 4-methylene- Catalog No.:AG0001H1 MDL No.: MF:C7H10O MW:110.1537 |
CAS No. 100281-23-0Phosphine, (dibromomethylene)[2,4,6-tris(1,1-dimethylethyl)phenyl]- Catalog No.:AG0001H0 MDL No.: MF:C19H29Br2P MW:448.2153 |
CAS No. 100281-24-1Phosphine, (dichloromethylene)[2,4,6-tris(1,1-dimethylethyl)phenyl]- Catalog No.:AG0001GZ MDL No.: MF:C19H29Cl2P MW:359.3133 |
CAS No. 100282-49-3Carbamic acid, (3-chloro-4-methylphenyl)-, 1,1-dimethylethyl ester (9CI) Catalog No.:AG0001GY MDL No.: MF:C12H16ClNO2 MW:241.7139 |
CAS No. 100282-53-9Butanoic acid, 4-chloro-2,2-dimethyl-, methyl ester Catalog No.:AG0001GX MDL No.: MF:C7H13ClO2 MW:164.6299 |
CAS No. 100282-87-91,2,5-Thiadiazole, 3-chloro-4-(4-methylphenyl)- Catalog No.:AG0001GW MDL No.: MF:C9H7ClN2S MW:210.6833 |
CAS No. 100286-97-3Catalog No.:AG0001GV MDL No.:MFCD00875852 MF:C15H15N3O4 MW:301.2973 |
CAS No. 100288-12-83-Benzofurancarboxylic acid, 5,6-dihydroxy-2-(2,4,6-trihydroxyphenyl)- Catalog No.:AG0001GU MDL No.: MF:C15H10O8 MW:318.2351 |
CAS No. 100288-36-6Catalog No.:AG0001GT MDL No.: MF:C15H22O3 MW:250.3334 |
CAS No. 100288-55-9Benzamide, N-(1-acetylcyclohexyl)- Catalog No.:AG0001GS MDL No.: MF:C15H19NO2 MW:245.3169 |
CAS No. 100288-67-32-Undecen-1-ol, 1-acetate, (2E)- Catalog No.:AG0001GR MDL No.: MF:C13H24O2 MW:212.3285 |
CAS No. 100289-16-5Ethanone, 1-(2-amino-4-ethyl-5-thiazolyl)- Catalog No.:AG0001GQ MDL No.:MFCD20717113 MF:C7H10N2OS MW:170.2321 |
CAS No. 100289-17-61-Propanone, 1-(2-amino-4-methyl-5-thiazolyl)- Catalog No.:AG0001GP MDL No.: MF:C7H10N2OS MW:170.2321 |
CAS No. 10029-04-62-Propenoic acid, 2-(hydroxymethyl)-, ethyl ester Catalog No.:AG0001HA MDL No.:MFCD01673859 MF:C6H10O3 MW:130.1418 |
CAS No. 10029-09-11,4-Cyclohexanedimethanamine, cis- Catalog No.:AG0001H9 MDL No.:MFCD20617651 MF:C8H18N2 MW:142.2419 |
CAS No. 10029-24-0Alanine, N,N'-(methylenedi-4,1-phenylene)bis[2-methyl-, dimethyl ester (9CI) Catalog No.:AG0001H8 MDL No.: MF:C23H30N2O4 MW:398.4953 |
CAS No. 10029-30-81,4-Benzenediamine, N1-(1-methylpropyl)- Catalog No.:AG0001H7 MDL No.: MF:C10H16N2 MW:164.2474 |
CAS No. 10029-31-9Benzenamine, 4-[(4-aminophenyl)methyl]-N-(1-methylethyl)- Catalog No.:AG0001H6 MDL No.: MF:C16H20N2 MW:240.3434 |
CAS No. 10029-91-1Aziridine, 2-(4-methoxyphenyl)- Catalog No.:AG0001H5 MDL No.: MF:C9H11NO MW:149.1897 |
CAS No. 100291-86-9Ethanone, 1-[2-[(6-O-D-apio-β-D-furanosyl-β-D-glucopyranosyl)oxy]-4-methoxyphenyl]- Catalog No.:AG0001GO MDL No.: MF: MW: |
CAS No. 100295-50-92-Cyclohexen-1-one, 4-(1,1-dimethylethyl)-, (4S)- Catalog No.:AG0001GN MDL No.: MF:C10H16O MW:152.2334 |
CAS No. 100297-82-32H-1-Benzopyran-2-one, 3-[4-(phenylmethoxy)phenyl]- Catalog No.:AG0001HD MDL No.: MF:C22H16O3 MW:328.3606 |
CAS No. 100298-31-52-Cyclopenten-1-one, 2-[(4-methylphenyl)sulfonyl]- Catalog No.:AG0001HC MDL No.: MF:C12H12O3S MW:236.2869 |
CAS No. 100299-08-94H-Pyrido[1,2-a]pyrimidin-4-one, 9-methyl-3-(2H-tetrazol-5-yl)-, potassium salt (1:1) Catalog No.:AG0001HB MDL No.:MFCD22575284 MF:C10H8KN6O MW:267.3084 |
CAS No. 1003-01-6Catalog No.:AG0001HZ MDL No.: MF:C31H62 MW:434.8240 |
CAS No. 1003-02-73,6,9,12,15,18,21,24,27,30,33,36-Dodecaoxanonatetracontan-1-ol Catalog No.:AG0001HY MDL No.: MF:C37H76O13 MW:728.9915 |
CAS No. 1003-04-9Catalog No.:AG0001HW MDL No.:MFCD00005412 MF:C4H6OS MW:102.1548 |
CAS No. 1003-07-2Catalog No.:AG0001HV MDL No.:MFCD09834764 MF:C3H3NOS MW:101.1270 |
CAS No. 1003-09-4Catalog No.:AG0001HU MDL No.:MFCD00005417 MF:C4H3BrS MW:163.0356 |
CAS No. 1003-10-7Catalog No.:AG0001HT MDL No.:MFCD00005479 MF:C4H6OS MW:102.1548 |
CAS No. 1003-14-1Catalog No.:AG0001HS MDL No.:MFCD00192124 MF:C5H10O MW:86.1323 |
CAS No. 1003-17-4Furan, tetrahydro-2,2-dimethyl- Catalog No.:AG0001HR MDL No.: MF:C6H12O MW:100.1589 |
CAS No. 1003-18-51H-Phosphole, 1-chloro-2,3-dihydro-, 1-oxide Catalog No.:AG0001HQ MDL No.: MF:C4H6ClOP MW:136.5166 |
CAS No. 1003-20-9Oxirane, 2,2-bis(chloromethyl)- Catalog No.:AG0001HP MDL No.:MFCD19232048 MF:C4H6Cl2O MW:140.9958 |
CAS No. 1003-21-01H-Imidazole, 5-bromo-1-methyl- Catalog No.:AG0001HO MDL No.:MFCD01632218 MF:C4H5BrN2 MW:160.9999 |
CAS No. 1003-22-13-Isothiazolidinone, 2-methyl- Catalog No.:AG0001HN MDL No.: MF:C4H7NOS MW:117.1695 |
CAS No. 1003-23-23H-1,2,4-Triazol-3-one, 4-amino-2,4-dihydro- Catalog No.:AG0001HM MDL No.:MFCD00233927 MF:C2H4N4O MW:100.0794 |
CAS No. 1003-28-7Catalog No.:AG0001HL MDL No.:MFCD02663413 MF:C6H13N MW:99.1741 |
CAS No. 1003-29-8Catalog No.:AG0001HK MDL No.:MFCD00005217 MF:C5H5NO MW:95.0993 |
CAS No. 1003-30-1Catalog No.:AG0001HJ MDL No.: MF:C6H12O MW:100.1589 |
CAS No. 1003-31-2Catalog No.:AG0001HI MDL No.:MFCD00005416 MF:C5H3NS MW:109.1490 |
CAS No. 1003-32-3Catalog No.:AG0001HH MDL No.:MFCD02179516 MF:C4H3NOS MW:113.1377 |
CAS No. 1003-33-4Cyclopropane, (2-methyl-1-propen-1-yl)- Catalog No.:AG0001HG MDL No.: MF:C7H12 MW:96.1702 |
CAS No. 1003-35-63H-1,2,4-Triazol-3-one, 5-amino-1,2-dihydro- Catalog No.:AG0001HF MDL No.:MFCD00970120 MF:C2H4N4O MW:100.0794 |
CAS No. 1003-38-9Furan, tetrahydro-2,5-dimethyl- Catalog No.:AG0001IO MDL No.:MFCD00005369 MF:C6H12O MW:100.1589 |
CAS No. 1003-40-34-Pyridinamine, hydrochloride (1:1) Catalog No.:AG0001IN MDL No.:MFCD00143257 MF:C5H7ClN2 MW:130.5755 |
CAS No. 1003-42-52H-Thiopyran-2-one, tetrahydro- Catalog No.:AG0001IM MDL No.:MFCD22054117 MF:C5H8OS MW:116.1814 |
CAS No. 1003-43-61,3,2-Dioxaborinane, 2-chloro- Catalog No.:AG0001IL MDL No.: MF:C3H6BClO2 MW:120.3425 |
CAS No. 1003-45-83(2H)-Thiophenone, dihydro-4,4-dimethyl- Catalog No.:AG0001IK MDL No.:MFCD18451858 MF:C6H10OS MW:130.2080 |
CAS No. 1003-46-9Thiophene, tetrahydro-2-methyl-, 1,1-dioxide Catalog No.:AG0001IJ MDL No.: MF:C5H10O2S MW:134.1967 |
CAS No. 1003-50-51H-Imidazole, 4,5-dibromo-1-methyl- Catalog No.:AG0001II MDL No.:MFCD00955568 MF:C4H4Br2N2 MW:239.8960 |
CAS No. 1003-51-62-Pyrrolidinone, 3-amino-1-hydroxy- Catalog No.:AG0001IH MDL No.:MFCD00069208 MF:C4H8N2O2 MW:116.1185 |
CAS No. 1003-52-75-Oxazolecarbonitrile, 4-methyl- Catalog No.:AG0001IG MDL No.:MFCD01111976 MF:C5H4N2O MW:108.0981 |
CAS No. 1003-55-02H-Pyrrol-5-amine, 3,4-dihydro-N,N-dimethyl- Catalog No.:AG0001IF MDL No.: MF:C6H12N2 MW:112.1729 |
CAS No. 1003-56-1Catalog No.:AG0001IE MDL No.:MFCD00039704 MF:C6H7NO MW:109.1259 |
CAS No. 1003-57-22H-Pyran-2-ol, 3-chlorotetrahydro- Catalog No.:AG0001ID MDL No.: MF:C5H9ClO2 MW:136.5768 |
CAS No. 1003-60-72-Methylthiazole-5-carbaldehyde Catalog No.:AG0001IC MDL No.:MFCD09864617 MF:C5H5NOS MW:127.1643 |
CAS No. 1003-61-85-Thiazolecarboxaldehyde, 2-amino- Catalog No.:AG0001IB MDL No.:MFCD02179570 MF:C4H4N2OS MW:128.1524 |
CAS No. 1003-64-1Catalog No.:AG0001IA MDL No.:MFCD00001662 MF:C8H14 MW:110.1968 |
CAS No. 1003-66-3Catalog No.:AG0001I9 MDL No.: MF:C6H5DO MW:95.1174 |
CAS No. 1003-67-4Catalog No.:AG0001I8 MDL No.:MFCD00006210 MF:C6H7NO MW:109.1259 |
CAS No. 1003-68-5Catalog No.:AG0001I7 MDL No.:MFCD00955788 MF:C6H7NO MW:109.1259 |
CAS No. 1003-73-2Catalog No.:AG0001I6 MDL No.:MFCD00006203 MF:C6H7NO MW:109.1259 |
CAS No. 1003-75-41,2,3,4,5,7,6,8-Hexathiadiazocine (7CI,8CI,9CI) Catalog No.:AG0001I5 MDL No.: MF:H2N2S6 MW:222.4193 |
CAS No. 1003-76-51,2,3,4,6,7,5,8-Hexathiadiazocine (7CI,8CI,9CI) Catalog No.:AG0001I4 MDL No.: MF:H2N2S6 MW:222.4193 |
CAS No. 1003-78-7Thiophene, tetrahydro-2,4-dimethyl-, 1,1-dioxide Catalog No.:AG0001I3 MDL No.:MFCD00005485 MF:C6H12O2S MW:148.2233 |
CAS No. 1003-80-11,4-Dithia-7-azaspiro[4.4]nonane (8CI,9CI) Catalog No.:AG0001I2 MDL No.: MF:C6H11NS2 MW:161.2882 |
CAS No. 1003-83-41,3-Dioxepin, 4,7-dihydro-2,2-dimethyl- Catalog No.:AG0001I1 MDL No.:MFCD22054122 MF:C7H12O2 MW:128.1690 |
CAS No. 1003-84-5Catalog No.:AG0001I0 MDL No.: MF:C8H17N MW:127.2273 |
CAS No. 1003-90-31H-Pyrrole, 2,3,4,5-tetramethyl- Catalog No.:AG0001JD MDL No.: MF:C8H13N MW:123.1955 |
CAS No. 1003-91-41H-Imidazole, 2,4,5-tribromo-1-methyl- Catalog No.:AG0001JC MDL No.:MFCD00955564 MF:C4H3Br3N2 MW:318.7920 |
CAS No. 1003-92-52H-1,3-Thiazine-2,4(3H)-dione, dihydro-3-methyl- Catalog No.:AG0001JB MDL No.: MF:C5H7NO2S MW:145.1796 |
CAS No. 1003-96-93-Furanmethanol, 2,5-dimethyl- Catalog No.:AG0001JA MDL No.:MFCD11646256 MF:C7H10O2 MW:126.1531 |
CAS No. 1003-98-1Benzenamine, 2-bromo-4-fluoro- Catalog No.:AG0001J9 MDL No.:MFCD00042462 MF:C6H5BrFN MW:190.0130 |
CAS No. 1003-99-2Benzenamine, 2-bromo-5-fluoro- Catalog No.:AG0001J8 MDL No.:MFCD00070750 MF:C6H5BrFN MW:190.0130 |
CAS No. 10030-31-6L-Phenylalanine, N-acetyl-L-phenylalanyl- Catalog No.:AG0001J7 MDL No.: MF:C20H22N2O4 MW:354.3997 |
CAS No. 10030-52-1L-Histidine, β-alanyl-3-methyl-, nitrate (1:?) Catalog No.:AG0001J6 MDL No.:MFCD00037001 MF:C10H17N5O6 MW:303.2719 |
CAS No. 10030-53-2D-glycero-D-gulo-Heptonic acid, calcium salt (2:1), dihydrate (9CI) Catalog No.:AG0001J5 MDL No.:MFCD00150972 MF:C14H30CaO18 MW:526.4552 |
CAS No. 10030-67-8D-Glucoside, O-α-D-glucopyranosyl-(1→3)-β-D-fructofuranosyl, hydrate (1:1) Catalog No.:AG0001J4 MDL No.:MFCD00149448 MF:C18H36O18 MW:540.4676 |
CAS No. 10030-73-6Catalog No.:AG0001J3 MDL No.: MF:C16H30O2 MW:254.4082 |
CAS No. 10030-74-79-Hexadecenoic acid, methyl ester, (9E)- Catalog No.:AG0001J2 MDL No.: MF:C17H32O2 MW:268.4348 |
CAS No. 10030-78-16H-Purin-6-one, 1,9-dihydro-2-(methylamino)- Catalog No.:AG0001J1 MDL No.: MF:C6H7N5O MW:165.1527 |
CAS No. 10030-80-5(2R,3R,4S,5S);-2,3,4,5,6-Pentahydroxyhexanal Catalog No.:AG0001J0 MDL No.:MFCD00063884 MF:C6H12O6 MW:180.1559 |
CAS No. 10030-85-0L-Mannose, 6-deoxy-, hydrate (1:1) Catalog No.:AG0001IZ MDL No.:MFCD00150842 MF:C6H14O6 MW:182.1718 |
CAS No. 10030-88-3Catalog No.:AG0001IY MDL No.: MF: MW: |
CAS No. 10030-90-7Butanedioic acid, iron(2+) salt (1:1) Catalog No.:AG0001IX MDL No.:MFCD00672154 MF:C4H4FeO4 MW:171.9172 |
CAS No. 100301-28-8Pyridinium, 2-[2-[4-(dipropylamino)phenyl]ethenyl]-1-methyl-, iodide (1:1) Catalog No.:AG0001IW MDL No.: MF:C20H27IN2 MW:422.3462 |
CAS No. 1003011-02-61H-Pyrazole-1-carboxylic acid, 5-amino-, 1,1-dimethylethyl ester Catalog No.:AG0001IV MDL No.:MFCD20702903 MF:C8H13N3O2 MW:183.2077 |
CAS No. 1003011-38-81H-Pyrazole-1-propanol, 3-amino- Catalog No.:AG0001IU MDL No.:MFCD16072175 MF:C6H11N3O MW:141.1710 |
CAS No. 1003012-96-1Ferrocene, 1-[(R)-(dimethylamino)[2-(diphenylphosphino)phenyl]methyl]-2-(diphenylphosphino)-, (2S)- Catalog No.:AG0001IT MDL No.: MF:C43H39FeNP2 MW:687.5690 |
CAS No. 1003013-76-0Oxetane, 3-[(phenylmethoxy)methyl]- Catalog No.:AG0001IS MDL No.:MFCD20482348 MF:C11H14O2 MW:178.2277 |
CAS No. 1003013-77-1Catalog No.:AG0001IR MDL No.:MFCD18909284 MF:C4H7IO MW:198.0023 |
CAS No. 1003013-83-9Cyclobutane, 3-(iodomethyl)-1,1-dimethoxy- Catalog No.:AG0001IQ MDL No.:MFCD12755813 MF:C7H13IO2 MW:256.0814 |
CAS No. 1003021-01-92-Piperidinone, 5-amino-, hydrochloride (1:1), (5R)- Catalog No.:AG0001IP MDL No.:MFCD03094720 MF:C5H11ClN2O MW:150.6066 |
CAS No. 1003021-83-74-Piperidinecarboxamide, 4-methyl- Catalog No.:AG0001JU MDL No.:MFCD13178874 MF:C7H14N2O MW:142.1989 |
CAS No. 1003025-51-1Quinazoline, 4-chloro-6-(4-fluorophenyl)- Catalog No.:AG0001JT MDL No.: MF:C14H8ClFN2 MW:258.6781 |
CAS No. 100303-39-79-Tetradecenoyl fluoride, (Z)- (9CI) Catalog No.:AG0001K2 MDL No.: MF:C14H25FO MW:228.3461 |
CAS No. 100303-57-9Oxirane, 2-[[3-(methoxydimethylsilyl)propoxy]methyl]- Catalog No.:AG0001K1 MDL No.: MF:C9H20O3Si MW:204.3388 |
CAS No. 100303-76-2Butanoic acid, 3-oxo-, cyclohexylmethyl ester Catalog No.:AG0001K0 MDL No.: MF:C11H18O3 MW:198.2588 |
CAS No. 100304-15-2Benzeneacetic acid, 4-(carboxymethoxy)-α-hydroxy- Catalog No.:AG0001JZ MDL No.: MF:C10H10O6 MW:226.1828 |
CAS No. 100304-60-7Glycinamide, L-tyrosyl-D-arginyl-L-phenylalanyl- Catalog No.:AG0001JY MDL No.: MF:C26H36N8O5 MW:540.6146 |
CAS No. 100304-79-8Butanoic acid, 3-oxo-, 3-chloropropyl ester Catalog No.:AG0001JX MDL No.: MF:C7H11ClO3 MW:178.6134 |
CAS No. 100304-88-9Acetamide, N-(5-fluoro-2-pyridinyl)- Catalog No.:AG0001JW MDL No.:MFCD05662406 MF:C7H7FN2O MW:154.1417 |
CAS No. 100304-95-8Benzenamine, N-[(3-methoxy-2-thienyl)methylene]-2,6-dimethyl- Catalog No.:AG0001JV MDL No.: MF:C14H15NOS MW:245.3400 |
CAS No. 1003042-27-0Quinazoline, 2,4-dichloro-6-(4-fluorophenyl)- Catalog No.:AG0001JS MDL No.: MF:C14H7Cl2FN2 MW:293.1232 |
CAS No. 1003042-41-8Boronic acid, B-(2-amino-5-chlorophenyl)- Catalog No.:AG0001JR MDL No.:MFCD12546460 MF:C6H7BClNO2 MW:171.3893 |
CAS No. 1003042-50-9Boronic acid, B-(5-amino-2-methylphenyl)- Catalog No.:AG0001JQ MDL No.:MFCD22192389 MF:C7H10BNO2 MW:150.9708 |
CAS No. 1003042-59-8Boronic acid, B-[2-chloro-5-(hydroxymethyl)phenyl]- Catalog No.:AG0001JP MDL No.:MFCD06659858 MF:C7H8BClO3 MW:186.4006 |
CAS No. 1003042-89-4Boronic acid, B-(5-ethoxy-2-formylphenyl)- Catalog No.:AG0001JO MDL No.:MFCD22421490 MF:C9H11BO4 MW:193.9922 |
CAS No. 1003042-92-9Boronic acid, B-(2-ethoxy-5-formylphenyl)- Catalog No.:AG0001JN MDL No.:MFCD09752822 MF:C9H11BO4 MW:193.9922 |
CAS No. 1003043-25-1Benzoic acid, 2-borono-, 1-(1,1-dimethylethyl) ester Catalog No.:AG0001JM MDL No.: MF:C11H15BO4 MW:222.0454 |
CAS No. 1003043-31-9Boronic acid, B-(2-bromo-3-chloro-4-pyridinyl)- Catalog No.:AG0001JL MDL No.:MFCD08690231 MF:C5H4BBrClNO2 MW:236.2588 |
CAS No. 1003043-34-2Boronic acid, B-(6-bromo-5-methyl-3-pyridinyl)- Catalog No.:AG0001JK MDL No.:MFCD08274468 MF:C6H7BBrNO2 MW:215.8403 |
CAS No. 1003043-37-5Boronic acid, B-[2-chloro-6-(1-methylethyl)-3-pyridinyl]- Catalog No.:AG0001JJ MDL No.:MFCD08274472 MF:C8H11BClNO2 MW:199.4424 |
CAS No. 1003043-40-0Boronic acid, B-(6-chloro-5-methyl-3-pyridinyl)- Catalog No.:AG0001JI MDL No.:MFCD03411564 MF:C6H7BClNO2 MW:171.3893 |
CAS No. 1003043-43-3Boronic acid, B-[6-[4-[(4-chlorophenyl)sulfonyl]-1-piperazinyl]-3-pyridinyl]- Catalog No.:AG0001JH MDL No.:MFCD23701647 MF:C15H17BClN3O4S MW:381.6422 |
CAS No. 1003043-46-6Boronic acid, B-(2,6-diethoxy-3-pyridinyl)- Catalog No.:AG0001JG MDL No.:MFCD11617267 MF:C9H14BNO4 MW:211.0228 |
CAS No. 1003043-49-9Boronic acid, B-[6-[3-(dimethylamino)propoxy]-3-pyridinyl]- Catalog No.:AG0001JF MDL No.:MFCD18262092 MF:C10H17BN2O3 MW:224.0646 |
CAS No. 1003043-55-7Boronic acid, B-(2-ethoxy-5-pyrimidinyl)- Catalog No.:AG0001JE MDL No.:MFCD07375134 MF:C6H9BN2O3 MW:167.9583 |
CAS No. 1003043-67-1Boronic acid, B-[6-(1-piperazinyl)-3-pyridinyl]- Catalog No.:AG0001K8 MDL No.:MFCD11975410 MF:C9H14BN3O2 MW:207.0374 |
CAS No. 1003043-73-91-Piperazinecarboxylic acid, 4-(4-borono-2-pyridinyl)-, 1-(1,1-dimethylethyl) ester Catalog No.:AG0001K7 MDL No.:MFCD18261480 MF:C14H22BN3O4 MW:307.1532 |
CAS No. 1003048-68-71H-Inden-1-one, 2,3-dihydro-7-(trifluoromethyl)- Catalog No.:AG0001K6 MDL No.:MFCD11040251 MF:C10H7F3O MW:200.1572 |
CAS No. 1003048-71-2Benzenepropanoic acid, 2-bromo-5-fluoro- Catalog No.:AG0001K5 MDL No.:MFCD11036290 MF:C9H8BrFO2 MW:247.0610 |
CAS No. 1003048-72-31H-Inden-1-one, 4-bromo-7-fluoro-2,3-dihydro- Catalog No.:AG0001K4 MDL No.:MFCD17677340 MF:C9H6BrFO MW:229.0457 |
CAS No. 1003048-74-51H-Inden-1-one, 7-bromo-2,3-dihydro-5-methoxy- Catalog No.:AG0001K3 MDL No.: MF:C10H9BrO2 MW:241.0813 |
CAS No. 100305-91-71,2,3-Thiadiazole-4-carboxaldehyde, 5-chloro- Catalog No.:AG0001KG MDL No.:MFCD07774237 MF:C3HClN2OS MW:148.5708 |
CAS No. 100305-93-91H-Pyrazole-5-carboxaldehyde, 1-(1-methylethyl)- Catalog No.:AG0001KF MDL No.:MFCD03130042 MF:C7H10N2O MW:138.1671 |
CAS No. 100305-95-1Benzenamine, 2-methyl-6-(methylthio)- Catalog No.:AG0001KE MDL No.:MFCD13677164 MF:C8H11NS MW:153.2446 |
CAS No. 100306-33-0Benzenemethanol, α-(2-chloroethyl)-, (αR)- Catalog No.:AG0001KD MDL No.:MFCD00075128 MF:C9H11ClO MW:170.6360 |
CAS No. 100306-34-1Benzenemethanol, α-(2-chloroethyl)-, (αS)- Catalog No.:AG0001KC MDL No.:MFCD00013309 MF:C9H11ClO MW:170.6360 |
CAS No. 100306-70-54-Pyridinamine, 3-nitro-N-(phenylmethyl)- Catalog No.:AG0001KB MDL No.:MFCD02045331 MF:C12H11N3O2 MW:229.2346 |
CAS No. 100307-96-8Prosta-4,13-dien-1-oic acid, 5,9-epoxy-11,15-dihydroxy-, (4Z,9α,11α,13E,15S)- (9CI) Catalog No.:AG0001KA MDL No.: MF:C20H32O5 MW:352.4651 |
CAS No. 100308-67-6Benzenamine, N,N-bis(4-bromophenyl)-4-methyl- Catalog No.:AG0001K9 MDL No.:MFCD22571645 MF:C19H15Br2N MW:417.1371 |
CAS No. 10031-14-8Boric acid (HBO2), magnesium salt, octahydrate (8CI,9CI) Catalog No.:AG0001KQ MDL No.: MF:B2H16Mg3O14 MW:334.6556 |
CAS No. 10031-20-6Manganese bromide (MnBr2), tetrahydrate (8CI,9CI) Catalog No.:AG0001KP MDL No.:MFCD00149791 MF:Br3Mn2O8+ MW:477.5833 |
CAS No. 10031-21-7Bromic acid, lead(2+) salt, monohydrate (8CI,9CI) Catalog No.:AG0001KO MDL No.: MF:Br2H2O7Pb MW:481.0197 |
CAS No. 10031-22-8Catalog No.:AG0001KN MDL No.:MFCD00011156 MF:Br2Pb MW:367.0080 |
CAS No. 10031-23-9Catalog No.:AG0001KM MDL No.: MF:Br2Ra MW:385.8080 |
CAS No. 10031-24-0Catalog No.:AG0001KL MDL No.:MFCD00011239 MF:Br2Sn MW:278.5090 |
CAS No. 10031-25-1Catalog No.:AG0001KK MDL No.:MFCD00016036 MF:Br6Cr3O2++ MW:667.4111 |
CAS No. 10031-26-2Catalog No.:AG0001KJ MDL No.:MFCD22631546 MF:Br3Fe MW:295.5570 |
CAS No. 10031-27-3Tellurium bromide (TeBr4), (T-4)- Catalog No.:AG0001KI MDL No.:MFCD00049575 MF: MW: |
CAS No. 10031-33-1Iodic acid (HIO3), calcium salt, hexahydrate (8CI,9CI) Catalog No.:AG0001LE MDL No.:MFCD00209635 MF:CaH12I2O12 MW:497.9750 |
CAS No. 10031-34-2Nitrous acid, calcium salt, monohydrate (8CI,9CI) Catalog No.:AG0001LD MDL No.:MFCD00673674 MF:CaH2N2O5 MW:150.1043 |
CAS No. 10031-37-5Sulfuric acid, chromium(3+) salt (3:2), pentadecahydrate (8CI,9CI) Catalog No.:AG0001LC MDL No.: MF:Cr2O12S3 MW:392.1800 |
CAS No. 10031-45-5Selenic acid, copper(2+) salt (1:1), pentahydrate (9CI) Catalog No.:AG0001LA MDL No.:MFCD00016059 MF:CuO4Se MW:206.5036 |
CAS No. 10031-58-0Pyridinium, 5-ethyl-2-methyl-1-(1,4,4,6,6-pentamethylheptyl)-, chloride (1:1) Catalog No.:AG0001L2 MDL No.: MF:C20H36ClN MW:325.9595 |
CAS No. 10031-68-2Disulfuric acid, ammonium salt (1:2) Catalog No.:AG0001L1 MDL No.: MF:H8N2O7S2 MW:212.2027 |
CAS No. 10031-82-0Catalog No.:AG0001L0 MDL No.:MFCD00003388 MF:C9H10O2 MW:150.1745 |
CAS No. 10031-86-4Butanoic acid, 1-phenylpropyl ester Catalog No.:AG0001KZ MDL No.: MF:C13H18O2 MW:206.2808 |
CAS No. 10031-88-6Catalog No.:AG0001KX MDL No.: MF:C9H16O MW:140.2227 |
CAS No. 10031-90-02-Furanpropanoic acid, ethyl ester Catalog No.:AG0001KW MDL No.: MF:C9H12O3 MW:168.1898 |
CAS No. 10031-92-2Catalog No.:AG0001KV MDL No.:MFCD00036553 MF:C11H18O2 MW:182.2594 |
CAS No. 10031-93-3Benzenebutanoic acid, ethyl ester Catalog No.:AG0001KU MDL No.:MFCD00026923 MF:C12H16O2 MW:192.2542 |
CAS No. 10031-96-6Phenol, 2-methoxy-4-(2-propen-1-yl)-, 1-formate Catalog No.:AG0001KT MDL No.: MF:C11H12O3 MW:192.2112 |
CAS No. 100310-79-01,4-Benzodioxin-2-ethanamine, 2,3-dihydro-, compd. with 2,4,6-trinitrophenol (1:1) Catalog No.:AG0001KS MDL No.: MF:C16H16N4O9 MW:408.3196 |
CAS No. 100313-54-02H-Pyran-6-carboxylic acid, 3,4-dihydro-4,5-dihydroxy- Catalog No.:AG0001LQ MDL No.:MFCD18814964 MF:C6H8O5 MW:160.1247 |
CAS No. 100313-81-3Benzenesulfonamide, 3-amino-4-chloro-N,N-dimethyl- Catalog No.:AG0001LP MDL No.:MFCD02704404 MF:C8H11ClN2O2S MW:234.7031 |
CAS No. 100314-68-9Catalog No.:AG0001LO MDL No.: MF:C12H20O2 MW:196.2860 |
CAS No. 100314-69-0Cyclohepta[c]pyran-3(1H)-one, octahydro-4,4-dimethyl- Catalog No.:AG0001LN MDL No.: MF:C12H20O2 MW:196.2860 |
CAS No. 100315-21-7Cyclohexanebutanoic acid, 3-oxo-, ethyl ester Catalog No.:AG0001LM MDL No.: MF:C12H20O3 MW:212.2854 |
CAS No. 100315-55-79-Undecynoic acid, 11-hydroxy-, methyl ester Catalog No.:AG0001LL MDL No.: MF:C12H20O3 MW:212.2854 |
CAS No. 100315-85-34-Octenedioic acid, 2,7-dimethyl-, 1,8-dimethyl ester Catalog No.:AG0001LK MDL No.: MF:C12H20O4 MW:228.2848 |
CAS No. 100316-65-24-Piperidinamine, 1-methyl-4-phenyl- Catalog No.:AG0001LJ MDL No.:MFCD11878795 MF:C12H18N2 MW:190.2847 |
CAS No. 100317-20-2Benzenamine, 2-methyl-5-(1-piperidinylsulfonyl)- Catalog No.:AG0001LI MDL No.:MFCD02706759 MF:C12H18N2O2S MW:254.3485 |
CAS No. 100317-27-9Acetamide, N-(4-amino-2,5-diethoxyphenyl)- Catalog No.:AG0001LH MDL No.: MF:C12H18N2O3 MW:238.2829 |
CAS No. 100317-81-5Hydrazinecarboxamide, 2-[1-(4-methyl-2-pyridinyl)pentylidene]- Catalog No.:AG0001LG MDL No.: MF:C12H18N4O MW:234.2975 |
CAS No. 3232-84-6Catalog No.:AG0001HE MDL No.:MFCD00005225 MF:C2H3N3O2 MW:101.0641 |
© 2019 Angene International Limited. All rights Reserved.